• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Prescription Drugs Market Research Reports
Category
Pharmaceutical (7179)
Biologics (273)
Biomarker (112)
Cancer (1067)
Clinical Trial (979)
Diabetes (184)
Drug Delivery System (140)
Drug Discovery (444)
Drug Regulation (122)
Gene Therapeutics & RNAi (99)
Generic Drugs (105)
Genome-based Drug Discovery (152)
Infectious Disease (335)
Molecular Targeted Therapeutics (200)
Neurodegenerative Disease (233)
OTC Drug (106)
Personalized Medicine (60)
Pharmaceutical Companies (1230)
Pipeline Analysis (1934)
Prescription Drugs (513)
Regenerative Medicine (147)
Vaccines (234)

Prescription Drugs Market Research Reports

These individual drug reports offer sales estimates, clinical assessment of pharmaceutical products, and analysis of factors impacting drug sales and the competitive landscape. They also include content regarding sales performance, as well as analysis of the trends, drivers and restraints shaping and defining the drug market.

Filter
Title Search
1 - 25 of 513 Products Sort by Display
Prescription Drugs Markets in China
Product code:269001
Published by Asia Market Information & Development
Published November 1, 2014 Price USD 4000
Content info 189 Pages
Sample available
Antibiotics Markets in China
Product code:86318
Published by Asia Market Information & Development
Published November 1, 2014 Price USD 4000
Content info 273 Pages
Sample available
China' s demand for Antibiotics has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply a...
Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options
Product code:318232
Published by GBI Research
Published October 31, 2014 Price USD 4995
Content info 109 Pages
Sample available
Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries
Product code:318231
Published by GBI Research
Published October 31, 2014 Price USD 4995
Content info 70 Pages
Sample available
Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation
Product code:318230
Published by GBI Research
Published October 31, 2014 Price USD 6995
Content info 93 Pages
Sample available
Pediatric Medicines: Global Markets
Product code:317508
Published by BCC Research
Published October 29, 2014 Price USD 6650
Content info 118 Pages
Sample available
Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for Leading Companies
Product code:214196
Published by Visiongain
Published October 27, 2014 Price USD 3004
Content info 335 Pages
Sample available
See what the future holds for asthma and COPD therapies. In this investigation you find revenue forecasting, growth rates and market shares. Included in the report are 114 tables, 210 charts and four research interviews, including two with executives from...
*
Product code:318429
Published by Transparency Market Research
Published October 17, 2014 Price USD 4795
Content info 188 Pages
Sample available
Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
Product code:318234
Published by GBI Research
Published September 30, 2014 Price USD 4995
Content info 163 Pages
Sample available
Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth
Product code:318233
Published by GBI Research
Published September 30, 2014 Price USD 4995
Content info 189 Pages
Sample available
Kadcyla (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
Product code:316766
Published by GlobalData
Published September 30, 2014 Price USD 3495
Content info 54 Pages
Sample available
Perjeta (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023
Product code:316765
Published by GlobalData
Published September 30, 2014 Price USD 3495
Content info 54 Pages
Sample available
PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023
Product code:316764
Published by GlobalData
Published September 30, 2014 Price USD 4995
Content info 154 Pages
Sample available
PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023
Product code:316763
Published by GlobalData
Published September 30, 2014 Price USD 4995
Content info 158 Pages
Sample available
PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023
Product code:316762
Published by GlobalData
Published September 30, 2014 Price USD 6995
Content info 196 Pages
Sample available
PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023
Product code:316761
Published by GlobalData
Published September 30, 2014 Price USD 4995
Content info 165 Pages
Sample available
Global Antibiotics Market 2014-2018
Product code:312950
Published by Infiniti Research Limited (Technavio)
Published September 17, 2014 Price USD 2500
Content info 96 Pages
Sample available
*
Product code:311926
Published by ROOTS ANALYSIS
Published September 5, 2014 Price USD 1899
Content info 134 Pages
Sample available
Tralokinumab (Asthma) - Forecast and Market Analysis to 2023
Product code:316089
Published by GlobalData
Published August 31, 2014 Price USD 3495
Content info 67 Pages
Sample available
Quilizumab (Asthma) - Forecast and Market Analysis to 2023
Product code:316088
Published by GlobalData
Published August 31, 2014 Price USD 3495
Content info 67 Pages
Sample available
Dupilumab (Asthma) - Forecast and Market Analysis to 2023
Product code:316087
Published by GlobalData
Published August 31, 2014 Price USD 3495
Content info 66 Pages
Sample available
Benralizumab (Asthma) - Forecast and Market Analysis to 2023
Product code:316086
Published by GlobalData
Published August 31, 2014 Price USD 3495
Content info 67 Pages
Sample available
Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023
Product code:316085
Published by GlobalData
Published August 31, 2014 Price USD 3495
Content info 66 Pages
Sample available
Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023
Product code:316084
Published by GlobalData
Published August 31, 2014 Price USD 3495
Content info 66 Pages
Sample available
Cinquil (Reslizumab) (Asthma) - Forecast and Market Analysis to 2023
Product code:316083
Published by GlobalData
Published August 31, 2014 Price USD 3495
Content info 66 Pages
Sample available